{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:31:48Z","timestamp":1791811908997,"version":"4.3.4"},"reference-count":225,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Arthritis is inflammation of the joints accompanied by osteochondral destruction. It can take many forms, including osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. These diseases share one commonality\u2014osteochondral destruction based on inflammation. The background includes a close interaction between osseous tissues and immune cells through various inflammatory cytokines. However, the tissues and cytokines that play major roles are different in each disease, and as a result, the mechanism of osteochondral destruction also differs. In recent years, there have been many findings regarding not only extracellular signaling pathways but also intracellular signaling pathways. In particular, we anticipate that the intracellular signals of osteoclasts, which play a central role in bone destruction, will become novel therapeutic targets. In this review, we have summarized the pathology of arthritis and the latest findings on the mechanism of osteochondral destruction, as well as present and future therapeutic strategies for these targets.<\/jats:p>","DOI":"10.3390\/cells8080818","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:58:16Z","timestamp":1564747096000},"page":"818","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review"],"prefix":"10.3390","volume":"8","author":[{"given":"Daisuke","family":"Tateiwa","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-2997","authenticated-orcid":false,"given":"Takashi","family":"Kaito","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Palmer","year":"2015","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","article-title":"The individual and socioeconomic impact of osteoarthritis","volume":"10","author":"Hunter","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_7","first-page":"S72","article-title":"Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis","volume":"30","author":"Furneri","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.21706","article-title":"Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: A 5-year analysis based on hospitalization records","volume":"64","author":"Piscitelli","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0950-3579(97)80011-8","article-title":"Economics of osteoarthritis: A global perspective","volume":"11","author":"March","year":"1997","journal-title":"Baillieres Clin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jb\/mvt049","article-title":"Immunology and bone","volume":"154","author":"Danks","year":"2013","journal-title":"J. Biochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.joca.2015.05.035","article-title":"Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy","volume":"23","author":"Larsson","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijom.2011.10.027","article-title":"Prolonged matrix metalloproteinase-3 high expression after cyclic compressive load on human synovial cells in three-dimensional cultured tissue","volume":"41","author":"Akamine","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.aanat.2005.07.003","article-title":"Pathomechanisms of cartilage destruction by mechanical injury","volume":"187","author":"Kurz","year":"2005","journal-title":"Ann. Anat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/322547a0","article-title":"Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage","volume":"322","author":"Saklatvala","year":"1986","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis","volume":"2","author":"Barr","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/bmj.312.7036.940","article-title":"Genetic influences on osteoarthritis in women: A twin study","volume":"312","author":"Spector","year":"1996","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1136\/annrheumdis-2012-203114","article-title":"A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip","volume":"73","author":"Evangelou","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.joca.2003.09.016","article-title":"Anatomy and physiology of the mineralized tissues: Role in the pathogenesis of osteoarthrosis","volume":"12","author":"Burr","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00223-014-9917-9","article-title":"Osteoarthritis pathogenesis: A review of molecular mechanisms","volume":"95","author":"Xia","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","article-title":"The role of the chondrocyte in osteoarthritis","volume":"43","author":"Goldring","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ncprheum0727","article-title":"Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: Destruction or repair?","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.25002","article-title":"Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development","volume":"60","author":"Little","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1479-7364-4-1-43","article-title":"Evolutionary divergence and functions of the ADAM and ADAMTS gene families","volume":"4","author":"Brocker","year":"2009","journal-title":"Hum. Genomics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro","volume":"434","author":"Stanton","year":"2005","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/ard.2007.086884","article-title":"Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes","volume":"68","author":"Yatabe","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrrheum.2014.209","article-title":"TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs","volume":"11","author":"Gomez","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1096\/fj.11-184861","article-title":"Response of chondrocytes to shear stress: Antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1","volume":"25","author":"Wang","year":"2011","journal-title":"FASEB J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/art.21951","article-title":"The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes","volume":"54","author":"Kim","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/biof.202","article-title":"Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes","volume":"38","author":"Campo","year":"2012","journal-title":"BioFactors"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.joca.2010.10.006","article-title":"HIF-2alpha as a possible therapeutic target of osteoarthritis","volume":"18","author":"Saito","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nm.2153","article-title":"Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/art.22041","article-title":"Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability","volume":"54","author":"Kamekura","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2055","article-title":"Modulating hedgehog signaling can attenuate the severity of osteoarthritis","volume":"15","author":"Lin","year":"2009","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101ra93","DOI":"10.1126\/scitranslmed.3002214","article-title":"Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis","volume":"3","author":"Sampson","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.joca.2007.06.006","article-title":"Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA","volume":"16","author":"Chen","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1073\/pnas.1207458110","article-title":"Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development","volume":"110","author":"Hosaka","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.2011.06258.x","article-title":"Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis","volume":"1240","author":"Wang","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","article-title":"Osteoarthritis development in novel experimental mouse models induced by knee joint instability","volume":"13","author":"Kamekura","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.0105-2896.2005.00329.x","article-title":"Role of nuclear factor-kappaB in the immune system and bone","volume":"208","author":"Jimi","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.4049\/jimmunol.0803544","article-title":"Adaptor proteins and Ras synergistically regulate IL-1-induced ADAMTS-4 expression in human chondrocytes","volume":"182","author":"Ahmad","year":"2009","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000121610","article-title":"Notch1, Jagged1, and HES5 are abundantly expressed in osteoarthritis","volume":"188","author":"Karlsson","year":"2008","journal-title":"Cells Tissues Organs"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1073\/pnas.1419699112","article-title":"Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium\/calmodulin-dependent protein kinase 2","volume":"112","author":"Sugita","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nm1409","article-title":"Carminerin contributes to chondrocyte calcification during endochondral ossification","volume":"12","author":"Yamada","year":"2006","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-157-3-201208070-00473","article-title":"Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis","volume":"157","author":"Rutjes","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","article-title":"Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis","volume":"19","author":"Bannuru","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.10777","article-title":"Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial","volume":"48","author":"Raynauld","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00018-007-7360-z","article-title":"Hyaluronan synthesis and degradation in cartilage and bone","volume":"65","author":"Bastow","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0300060517723182","article-title":"Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial","volume":"46","author":"Wang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/ard.2011.149849","article-title":"Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: A double blind, randomised trial on structure modification","volume":"71","author":"Verbruggen","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/ar4044","article-title":"Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee","volume":"14","author":"Maksymowych","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Fidelix, T.S., Macedo, C.R., Maxwell, L.J., and Fernandes Moca Trevisani, V. (2014). Diacerein for osteoarthritis. Cochrane Database Syst. Rev., Cd005117.","DOI":"10.1002\/14651858.CD005117.pub3"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomised controlled trial","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00296-014-3100-5","article-title":"Effects of intra-articular clodronate in the treatment of knee osteoarthritis: Results of a double-blind, randomized placebo-controlled trial","volume":"35","author":"Rossini","year":"2015","journal-title":"Rheumatol. Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s10067-017-3681-y","article-title":"Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: A randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation)","volume":"36","author":"Saviola","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kato, Y., Hiasa, M., Ichikawa, R., Hasuzawa, N., Kadowaki, A., Iwatsuki, K., Shima, K., Endo, Y., Kitahara, Y., and Inoue, T. (2017). Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc. Natl. Acad. Sci. USA, 201704847.","DOI":"10.1073\/pnas.1704847114"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Valenti, M.T., Mottes, M., Biotti, A., Perduca, M., Pisani, A., Bovi, M., Deiana, M., Cheri, S., and Dalle Carbonare, L. (2017). Clodronate as a Therapeutic Strategy against Osteoarthritis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122696"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"iv9","DOI":"10.1093\/rheumatology\/kep274","article-title":"Strontium ranelate improves bone microarchitecture in osteoporosis","volume":"48","author":"Hamdy","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1359\/jbmr.2001.16.2.299","article-title":"Strontium ranelate increases cartilage matrix formation","volume":"16","author":"Henrotin","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","article-title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial","volume":"72","author":"Reginster","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/14740338.2014.939169","article-title":"Cardiac concerns associated with strontium ranelate","volume":"13","author":"Reginster","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-neuro-072116-031121","article-title":"Nerve Growth Factor and Pain Mechanisms","volume":"40","author":"Denk","year":"2017","journal-title":"Ann. Rev. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar4443","article-title":"Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: Possible involvement in osteoarthritis pain","volume":"16","author":"Pecchi","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","year":"1987","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-204905","article-title":"Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain","volume":"74","author":"Schnitzer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","article-title":"Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee","volume":"155","author":"Tiseo","year":"2014","journal-title":"Pain"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/j.1742-4658.2012.08598.x","article-title":"Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1beta","volume":"279","author":"Campo","year":"2012","journal-title":"FEBS J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"De Seny, D., Cobraiville, G., Charlier, E., Neuville, S., Esser, N., Malaise, D., Malaise, O., Calvo, F.Q., Relic, B., and Malaise, M.G. (2013). Acute-phase serum amyloid a in osteoarthritis: Regulatory mechanism and proinflammatory properties. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066769"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1196\/annals.1317.045","article-title":"VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts","volume":"1070","author":"Juarranz","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/art.27437","article-title":"Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line","volume":"62","author":"Iacono","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10059-009-0026-y","article-title":"Inhibition of homodimerization of toll-like receptor 4 by 6-shogaol","volume":"27","author":"Ahn","year":"2009","journal-title":"Mol. Cells"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: New regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joca.2015.10.018","article-title":"MicroRNAs: Exploring new horizons in osteoarthritis","volume":"24","author":"Nugent","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11914-014-0229-9","article-title":"MicroRNAs in cartilage development, homeostasis, and disease","volume":"12","author":"Mirzamohammadi","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/art.24745","article-title":"MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses","volume":"60","author":"Miyaki","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Iliopoulos, D., Malizos, K.N., Oikonomou, P., and Tsezou, A. (2008). Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003740"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2017.02.038","article-title":"Exosomes as novel bio-carriers for gene and drug delivery","volume":"521","author":"Jiang","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.24762","article-title":"Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a","volume":"60","author":"Nagata","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199410063311401","article-title":"Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation","volume":"331","author":"Brittberg","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21060","article-title":"Autologous chondrocyte implantation in the knee: Systematic review and economic evaluation","volume":"21","author":"Mistry","year":"2017","journal-title":"Health Technol. Assess."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.biopha.2018.11.099","article-title":"Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives","volume":"109","author":"Harrell","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"674","DOI":"10.5312\/wjo.v8.i9.674","article-title":"Mesenchymal stem cells for cartilage regeneration in osteoarthritis","volume":"8","author":"Kristjansson","year":"2017","journal-title":"World J. Orthop."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00264-014-2569-6","article-title":"Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro","volume":"39","author":"Okumachi","year":"2015","journal-title":"Int. Orthop."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fimmu.2018.01642","article-title":"Characteristics and Immunomodulating Functions of Adipose-Derived and Bone Marrow-Derived Mesenchymal Stem Cells Across Defined Human Leukocyte Antigen Barriers","volume":"9","author":"Waldner","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/jbm.a.36087","article-title":"Recent strategies in cartilage repair: A systemic review of the scaffold development and tissue engineering","volume":"105","author":"Rai","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.arthro.2015.09.010","article-title":"Adipose-Derived Mesenchymal Stem Cells With Microfracture Versus Microfracture Alone: 2-Year Follow-up of a Prospective Randomized Trial","volume":"32","author":"Koh","year":"2016","journal-title":"Arthroscopy"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2106\/JBJS.M.00058","article-title":"Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: A randomized, double-blind, controlled study","volume":"96","author":"Vangsness","year":"2014","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: Inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.24385","article-title":"Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis","volume":"60","author":"Toes","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/32.10.903","article-title":"Twin concordance rates for rheumatoid arthritis: Results from a nationwide study","volume":"32","author":"Silman","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1196\/annals.1361.067","article-title":"Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary","volume":"1051","author":"Kapitany","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ng.2231","article-title":"Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population","volume":"44","author":"Okada","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"key":"ref_108","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am. Journal Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/ar3380","article-title":"Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis","volume":"13","author":"Braun","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1073\/pnas.87.12.4828","article-title":"Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op\/op) mouse","volume":"87","author":"Bartocci","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors","volume":"91","author":"Tanaka","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.39563","article-title":"Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts","volume":"68","author":"Araki","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","article-title":"Fos\/AP-1 proteins in bone and the immune system","volume":"208","author":"Wagner","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/emboj\/20.6.1271","article-title":"Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis","volume":"20","author":"Kobayashi","year":"2001","journal-title":"EMBO J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Chen, S.J., Lin, G.J., Chen, J.W., Wang, K.C., Tien, C.H., Hu, C.F., Chang, C.N., Hsu, W.F., Fan, H.C., and Sytwu, H.K. (2019). Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061332"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/BRS.0b013e318256b584","article-title":"Effect of biological agents on cervical spine lesions in rheumatoid arthritis","volume":"37","author":"Kaito","year":"2012","journal-title":"Spine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Steeland, S., Libert, C., and Vandenbroucke, R.E. (2018). A New Venue of TNF Targeting. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201804.0015.v1"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: Past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.3748\/wjg.v22.i42.9300","article-title":"Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases","volume":"22","author":"Billmeier","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2004.09.004","article-title":"TNF-alpha, rheumatoid arthritis, and heart failure: A rheumatological dilemma","volume":"4","author":"Atzeni","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: A paradigm for cytokines","volume":"258","author":"Kishimoto","year":"1992","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.smim.2014.01.009","article-title":"A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy","volume":"26","author":"Tanaka","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer, gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem. J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/annrheumdis-2013-204405","article-title":"Sarilumab, a fully human monoclonal antibody against IL-6Ralpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: Efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial","volume":"73","author":"Huizinga","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e000607","DOI":"10.1136\/rmdopen-2017-000607","article-title":"Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: A biomarker substudy of the phase 3 TARGET study","volume":"4","author":"Gabay","year":"2018","journal-title":"RMD Open"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: Preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/annrheumdis-2014-206478","article-title":"Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate","volume":"74","author":"Keystone","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","article-title":"Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: Results from the RA-BUILD study","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2016-209821","article-title":"Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1136\/annrheumdis-2017-211259","article-title":"Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: Secondary analyses from the RA-BEAM study","volume":"76","author":"Keystone","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.curtheres.2007.12.001","article-title":"Abatacept for the treatment of rheumatoid arthritis: A review","volume":"68","author":"Kaine","year":"2007","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3899\/jrheum.130263","article-title":"Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial","volume":"41","author":"Kremer","year":"2014","journal-title":"J. Rheumatol."},{"key":"ref_148","first-page":"562","article-title":"Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis","volume":"35","author":"Fukuyo","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1084\/jem.184.1.31","article-title":"A role for Bruton\u2018s tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2","volume":"184","author":"Takata","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/eji.1830231210","article-title":"The Bruton\u2019s tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages","volume":"23","author":"Verschuren","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1074\/jbc.M708935200","article-title":"The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13075-016-0988-z","article-title":"HM71224, a novel Bruton\u2019s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: A potential drug for rheumatoid arthritis","volume":"18","author":"Park","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.179.5.1725","article-title":"Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling","volume":"179","author":"Kurosaki","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2016.00078","article-title":"Targeting Syk in Autoimmune Rheumatic Diseases","volume":"7","author":"Deng","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2007.03.543","article-title":"Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor","volume":"124","author":"Pine","year":"2007","journal-title":"Clin. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.biochem.70.1.535","article-title":"Synthesis and function of 3-phosphorylated inositol lipids","volume":"70","author":"Vanhaesebroeck","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M","article-title":"Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt","volume":"44","author":"Zhang","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/ar3019","article-title":"Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice","volume":"12","author":"Toyama","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1097\/MD.0000000000001326","article-title":"Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/art.30281","article-title":"Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice","volume":"63","author":"Bluml","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1073\/pnas.1019536108","article-title":"MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis","volume":"108","author":"Alivernini","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"23910","DOI":"10.3390\/ijms141223910","article-title":"Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-alpha and IL-1beta in PBMCs","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"Chaudhuri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): Characterization of the classical HDAC family","volume":"370","author":"Caron","year":"2003","journal-title":"Biochem. J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/ard.2011.154211","article-title":"Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay","volume":"71","author":"Grabiec","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis","volume":"63","author":"Vojinovic","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/annrheumdis-2015-209064","article-title":"Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes","volume":"76","author":"Angiolilli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"ii56","DOI":"10.1093\/rheumatology\/kew345","article-title":"Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis","volume":"55","author":"Goldring","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10067-016-3263-4","article-title":"IL-23\/IL-17 axis in spondyloarthritis-bench to bedside","volume":"35","author":"Raychaudhuri","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000274","article-title":"New therapies for psoriasis and psoriatic arthritis","volume":"28","author":"Ritchlin","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","article-title":"The roles of IL-17A in inflammatory immune responses and host defense against pathogens","volume":"226","author":"Iwakura","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/448416a","article-title":"Immunology: Narcissistic helpers","volume":"448","author":"Palmer","year":"2007","journal-title":"Nature"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: A unique pathway in immune-mediated diseases: Psoriasis, psoriatic arthritis and rheumatoid arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2016.00057","article-title":"The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH","volume":"7","author":"Pacifici","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"American J. Hum. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/rheumatology\/keh589","article-title":"Recurrence risk for psoriasis and psoriatic arthritis within sibships","volume":"44","author":"Myers","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: Genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.berh.2014.10.010","article-title":"Genetics of psoriatic arthritis","volume":"28","author":"Rahman","year":"2014","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","article-title":"Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis","volume":"76","author":"Thorarensen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.2854","article-title":"Primed for inflammation: Enthesis-resident T cells","volume":"18","author":"Lories","year":"2012","journal-title":"Nat. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: Possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"Lebre","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar3817","article-title":"Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features","volume":"14","author":"Celis","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","article-title":"IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis","volume":"18","author":"Shaw","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_193","first-page":"488","article-title":"Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: A novel cytokine that could contribute to new bone formation in spondyloarthropathies","volume":"56","author":"Jones","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/art.11389","article-title":"Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis","volume":"48","author":"Lories","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis","volume":"115","author":"Lories","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/art.37876","article-title":"Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor alpha inhibitor therapy: Results from the Danish Nationwide DANBIO Registry","volume":"65","author":"Glintborg","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","article-title":"Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(18)30952-8","article-title":"Efficacy and safety of guselkumab in patients with active psoriatic arthritis: A randomised, double-blind, placebo-controlled, phase 2 study","volume":"391","author":"Deodhar","year":"2018","journal-title":"Lancet"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/art.39685","article-title":"Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis","volume":"68","author":"Landewe","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","article-title":"Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: Results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1","volume":"76","author":"Mease","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2016-209831","article-title":"A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14728214.2013.807339","article-title":"Emerging therapies for rheumatoid arthritis","volume":"18","author":"Jacques","year":"2013","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_210","unstructured":"(2019, June 01). Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis (EXCEED 1), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02745080."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/rheumatology\/key069","article-title":"Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis","volume":"58","author":"Miyagawa","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.39700","article-title":"The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis","volume":"68","author":"Mease","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis","volume":"377","author":"Mease","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1615977","article-title":"Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors","volume":"377","author":"Gladman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"Mease","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-018-0746-0","article-title":"Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?","volume":"20","author":"Elalouf","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_217","unstructured":"(2019, June 01). Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03881059."},{"key":"ref_218","unstructured":"(2019, June 01). A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects with Active Psoriatic Arthritis, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03963401."},{"key":"ref_219","unstructured":"(2019, June 01). A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects with Psoriatic Arthritis, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02671188."},{"key":"ref_220","unstructured":"(2019, June 01). Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis (FLORA), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03058900."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"11594","DOI":"10.1073\/pnas.1930781100","article-title":"A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q\/J mice to infection and autoimmunity","volume":"100","author":"Shaw","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","article-title":"Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis","volume":"379","author":"Papp","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","article-title":"Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2","volume":"272","author":"Hieshima","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39259","article-title":"Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases","volume":"68","author":"Scher","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/exd.13463","article-title":"The Akkermansia muciniphila is a gut microbiota signature in psoriasis","volume":"27","author":"Tan","year":"2018","journal-title":"Exp. Dermatol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/8\/818\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:55Z","timestamp":1760188375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/8\/818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":225,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["cells8080818"],"URL":"https:\/\/doi.org\/10.3390\/cells8080818","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]}}}